Complete Case details are given below :
Case Name : Roche Holding AG: Funding the Genentech Acquisition
Authors : Michael J. Schill, Brett Durick, Drew Chambers
Source : Darden School of Business
Case ID : UV5641
Discipline : Finance
Case Length : 18 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
This case examines the decision by the Swiss pharmaceutical Roche Holding AG (Roche) to offer a record $42 billion bond in February 2009. In light of a pending acquisition of U.S. biotechnology leader, Genentech, Roche management planned to sell $32 billion in bonds at various maturities from 1 year to 30 years and in three different currencies (U.S. dollar, euro, and British pound). In a context of substantial uncertainty in both world financial markets and the value of the Genentech deal, students are introduced to the pricing of corporate bonds by being invited to price Roche’s bold global offering.
Click Here to place your order
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
Cordially,
Case Solutions Hub
